Navigation Links
Immucor Announces Fiscal Fourth Quarter Results
Date:7/23/2009

y selecting the webcast link. For those unable to listen to the live broadcast of the call, a replay will be available shortly after completion of the call and will be archived on Immucor's website for approximately 60 days. Additionally, a replay of the call will be available for one week beginning at noon on July 24, 2009 by calling 1-866-453-1998 (Passcode: 2583).

About Immucor

Founded in 1982, Immucor manufactures and sells a complete line of reagents and systems used by hospitals, reference laboratories and donor centers to detect and identify certain properties of the cell and serum components of blood prior to transfusion. Immucor markets a complete family of automated instrumentation for all of its market segments. For more information on Immucor, please visit our website at www.immucor.com.

Safe Harbor Statement

This press release contains statements that are "forward-looking statements" as that term is defined under federal securities laws. Forward-looking statements contained in this press release include the intent, belief or current expectations of the Company and members of its management team with respect to the Company's future business operations as well as the assumptions upon which such statements are based. Forward-looking statements include specifically, but are not limited to: fiscal 2010 revenue projections, gross margin projections, fully diluted earnings per share projections and Quality Process Improvement Project projections, including projected expenses and completion date. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. In addition, results for one fiscal quarter are not necessarily indicative of results for any future per
'/>"/>

SOURCE Immucor, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Immucor Appoints Chief Operating Officer
2. Immucor Submits 10-Day Response to FDA; Establishes Product Surveillance and Improvement Department
3. Immucor to Announce Fiscal Fourth Quarter Financial Results on Thursday, July 23, 2009
4. Immucor Announces Fiscal Year 2010 Guidance
5. Immucor to Announce Fiscal 2010 Guidance on Monday, June 1, 2009
6. Immucor to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference
7. Immucor Receives Subpoena From Department of Justice
8. Immucor Announces Fiscal Third Quarter Results
9. Immucor Announces New Vice President, Operations
10. Immucor Announces Fiscal Second Quarter Results; Raises Fiscal 2009 EPS Guidance
11. Immucor Closes BioArray Acquisition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... VA, May 21, 2013The Journal of the ... today released its June issue, which includes a ... Pediatric Drug-Resistant Tuberculosis. It establishes standardized definitions, ... research. This is the first step as ... visibility and share evidence and resources that can ...
(Date:5/21/2013)... N.C. An attack on glioblastoma brain tumor cells ... in an early study to establish the proper dose ... treatment, developed at Duke and tested in an ongoing ... cells have an abundance of receptors that work like ... the cells. , The investigational therapy, known as ...
(Date:5/21/2013)... Boulder, CO (PRWEB) May 21, 2013 ... hearing device from Sophono, Inc., experience audiological results ... – and with many fewer complications, according to ... another independent verification that Sophono’s abutment-free technology performs ... device – but with many fewer complications,” says ...
(Date:5/21/2013)... York, NY (PRWEB) May 21, 2013 Diehard ... two international powerhouse teams - the game between ... coming 23rd of May 2013. These two teams are ... and they are bringing their A-game to the Busch Stadium, ... , This will be the first time that a professional ...
(Date:5/21/2013)... The risk of sudden infant death syndrome (SIDS) is ... a new study finds. British researchers noted that ... do not drink, use illegal drugs or smoke. They ... cause of infant death in developed countries, would drop ... In the United States, all parents are advised ...
Breaking Medicine News(10 mins):Health News:JPIDS: Releases consensus statement on research definitions for drug-resistant TB in children 2Health News:JPIDS: Releases consensus statement on research definitions for drug-resistant TB in children 3Health News:Poliovirus vaccine trial shows early promise for recurrent glioblastoma 2Health News:Abutment-Free Sophono Systems Produce Comparable Study Results to Cochlear’s Baha Products, With Fewer Complications 2Health News:Abutment-Free Sophono Systems Produce Comparable Study Results to Cochlear’s Baha Products, With Fewer Complications 3Health News:Manchester City vs. Chelsea FC Tickets: Cheap Concert Tickets has Slashed Prices on Manchester City vs. Chelsea FC Tickets at Busch Stadium in St. Louis, MO 2Health News:Bed-Sharing Raises SIDS Risk Fivefold, Study Finds 2
... HealthDay Reporter , TUESDAY, Nov. 1 (HealthDay News) -- ... of developing cancer compared to the general population. And that ... to new research. In any given year, ... just 0.7 percent. And experts say the benefits of transplantation ...
... State University (ASU) and California State University, Long Beach ... trained in the skills and equipped with the tools ... of their lives. In early 2012 the universities ... to pursue studies and work experience in multiple fields ...
... -- Americans spend upwards of $40 billion a year on dieting ... eating strategy is basic awareness -- what,s on the plate. ... not: computer scientists at the Harvard School of Engineering and Applied ... photo of your meal and let the crowd do the rest. ...
... Steven Reinberg HealthDay Reporter , TUESDAY, Nov. 1 ... overdoses has tripled in a decade, hitting a peak of ... "The unfortunate and shocking news is that we are in ... country," Dr. Thomas R. Frieden, director of the U.S. Centers ...
... one in 500 Swedes carry a genetic mutation which can ... lifestyle changes, but quality of life can be maintained with ... the Sahlgrenska Academy at the University of Gothenburg, Sweden. ... children and adolescents is the heart muscle disease hypertrophic cardiomyopathy. ...
... and a lurching bus are an equation that is difficult ... getting the shopping home on public transport can be an ... University of Gothenburg, Sweden, is now enlisting the help ... in everyday logistics, and it is hoped that the results ...
Cached Medicine News:Health News:Cancer Risk Doubles After Organ Transplant, Study Finds 2Health News:Cancer Risk Doubles After Organ Transplant, Study Finds 3Health News:NSF-funded research fellowship program to focus on producing experts to aid people with disabilities 2Health News:NSF-funded research fellowship program to focus on producing experts to aid people with disabilities 3Health News:NSF-funded research fellowship program to focus on producing experts to aid people with disabilities 4Health News:NSF-funded research fellowship program to focus on producing experts to aid people with disabilities 5Health News:NSF-funded research fellowship program to focus on producing experts to aid people with disabilities 6Health News:Crowdsourcing nutrition in a snap 2Health News:Crowdsourcing nutrition in a snap 3Health News:Crowdsourcing nutrition in a snap 4Health News:Deaths From Abuse of Painkillers Triple in a Decade: CDC 2Health News:Deaths From Abuse of Painkillers Triple in a Decade: CDC 3Health News:Research supports broader screening for sudden cardiac death 2Health News:Senior citizens as co-researchers to improve urban planning 2
(Date:5/21/2013)... Abaxis, Inc. (NasdaqGS: ABAX), a medical products ... Martin Mulroy , chief commercial officer ... Veterinary Conference on Wednesday, May 29, 2013 at 11:30 ... Parker Meridien Hotel in New York City ... develops, manufactures, markets and sells portable blood analysis systems ...
(Date:5/21/2013)... , May 21, 2013 Ceregene, Inc. ... analysis of its double-blind, randomized, controlled Phase 2b ... gene therapy product designed to deliver the neurotrophic ... identified a more robust response to CERE-120 in ... treatment relative to those diagnosed 10 years or ...
(Date:5/21/2013)... 2013   RxAlly , a first-of-its-kind alliance ... the publication of a white paper entitled Personalized ... The white paper highlights an unprecedented solution for ... engagement to avert strains on the health care ... a range of individually-tailored, pharmacist-provided clinical and consultative ...
Breaking Medicine Technology:Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference 2Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 2Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 3Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 4Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 5RxAlly Releases White Paper on Necessity of Personalized Pharmacist Care 2RxAlly Releases White Paper on Necessity of Personalized Pharmacist Care 3
... Society for Aesthetic Plastic,Surgery,s Annual Meeting, NEW ... surgical and nonsurgical cosmetic enhancement are being introduced ... deliver what they promise? Are,the results of minimally ... downtime, comparable to more extensive procedures? Are these,new ...
... unmet needs of the lumbar ... ... CoreSpine Technologies, LLC, an,emerging spinal device company announced today the expansion ... minimally invasive fusion., The development of CoreSpine,s Technologies, initial prototype,concentrated ...
Cached Medicine Technology:Got Fat?: Plastic Surgeons Review Fat-Melting and Fat-Grafting Procedures 2Got Fat?: Plastic Surgeons Review Fat-Melting and Fat-Grafting Procedures 3CoreSpine Technologies Expands Spinal Disc Site Preparation Efforts 2
VG2 PLIF (Parallel) Posterior lumbar interbody fusion. Frozen preservation. Consists of two outer cortical planks, center cancellous plank, all from the same donor, held together by two press-fit cor...
An all-cortical structure provides the structural benefits of cortical bone. Precision machined to exact specifications to promote healthy lordosis and vertebral body distraction....
Solid cortical spacers with a natural anatomic fibular shape....
... Allografts are comprised of a ... strength and an enlarged center ... of preferred bone graft material ... instruments facilitate the insertion of ...
Medicine Products: